Serum and vitreous levels of visfatin in patients with diabetic retinopathy

Medical Science Monitor

Volumn 20, Issue , 2014, Pages 2729-2732

  Wang, Yongqiang ^a   Yuan, Ye ^a   Jiang, Hua ^a  

^a JINAN MILITARY GENERAL HOSPITAL   (China)

Author keywords

Adipokines; Angiogenesis inducing agents; Diabetic retinopathy

Indexed keywords

NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DIABETIC RETINOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; VITREOUS BODY; BLOOD; CASE CONTROL STUDY; ENZYMOLOGY; MIDDLE AGED;

CASE-CONTROL STUDIES; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; VITREOUS BODY;

EID: 84919438241     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.891292     Document Type: Article

References (18)

1. Nawaz MI, Abouammoh M, Khan HA et al: Novel drugs and their targets in the potential treatment of diabetic retinopathy. Med Sci Monit, 2013; 19: 300-8.
2. Gustavsson C, Agardh CD, Agardh E: Profile of intraocular tumour necrosis factor-a and interleukin-6 in diabetic subjects with different degrees of diabetic retinopathy. Acta Ophthalmol, 2013; 91: 445-52.
3. Ellis TP, Choudhury RH, Kaul K et al: Diabetic retinopathy and atherosclerosis: is there a link? Curr Diabetes Rev, 2013; 9: 146-60.
4. Gologorsky D, Thanos A, Vavvas D: Therapeutic interventions against inflammatory and angiogenic mediators in proliferative diabetic retinopathy. Mediators Inflamm. 2012; 2012: 629452.
5. Fukuhara A, Matsuda M, Nishizawa M et al: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science, 2005; 307: 426-30.
6. Bełtowski J: Apelin and visfatin: unique "beneficial" adipokines upregulated in obesity? Med Sci Monit, 2006; 12(6): RA112-19.
7. Park JW, Kim WH, Shin SH et al: Visfatin exerts angiogenic effects on human umbilical vein endothelial cells through the mTOR signaling pathway. Biochim Biophys Acta, 2011; 1813: 763-71.
8. Esteghamati A, Alamdari A, Zandieh A et al: Serum visfatin is associated with type 2 diabetes mellitus independent of insulin resistance and obesity. Diabetes Res Clin Pract, 2011; 91: 154-58.
9. Stadler M, Storka A, Theuer EA et al: Adipokines in type 1 diabetes after successful pancreas transplantation: normal visfatin and retinol-binding-protein-4, but increased total adiponectin fasting concentrations. Clin Endocrinol (Oxf), 2010; 72: 763-69.
10. Kaygusuz I, Gumus II, Yılmaz S et al: Serum levels of visfatin and possible interaction with iron parameters in gestational diabetes mellitus. Gynecol Obstet Invest, 2013; 75: 203-9.
11. Al-Lahham SH, Roelofsen H, Priebe M et al: Regulation of adipokine production in human adipose tissue by propionic acid. Eur J Clin Invest, 2010; 40: 401-7.
12. Gariano RF, Nath AK, D’Amico DJ et al: Elevation of vitreous leptin in diabetic retinopathy and retinal detachment. Invest Ophthalmol Vis Sci, 2000; 41: 3576-81.
13. Osawa H, Ochi M, Kato K et al: Serum resistin is associated with the severity of microangiopathies in type 2 diabetes. Biochem Biophys Res Commun, 2007; 355: 342-46.
14. Tao Y, Lu Q, Jiang YR et al: Apelin in plasma and vitreous and in fibrovascular retinal membranes of patients with proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci, 2010; 51: 4237-42.
15. Yilmaz MI, Sonmez A, Acikel C et al: Adiponectin may play a part in the pathogenesis of diabetic retinopathy. Eur J Endocrinol, 2004; 151: 135-40.
16. Abu El-Asrar AM, Nawaz MI, Kangave D et al: Angiogenesis regulatory factors in the vitreous from patients with proliferative diabetic retinopathy. Acta Diabetol, 2013; 50(4): 545-51.
17. Kim SR, Bae SK, Choi KS et al: Visfatin promotes angiogenesis by activation of extracellular signal-regulated kinase 1/2. Biochem Biophys Res Commun, 2007; 357: 150-56.
18. Xiao J, Xiao ZJ, Liu ZG et al: Involvement of dimethylarginine dimethylaminohydrolase-2. in visfatin-enhanced angiogenic function of endothelial cells. Diabetes Metab Res Rev, 2009; 25: 242-49.